Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Ministry of Food and Drug Safety (21153MFDS601)
- License Information
-
More Information
Article History
Received: 10 February 2025
Accepted: 6 August 2025
First Online: 2 September 2025
Declarations
:
: Prof. Dong Keon Yon reports being funded by the GCS to conduct clinical trials in collaboration with Agence Nationale de Se´curite´ du Me´dicament et des Produits de Sante´ (ANSM). No other potential conflict of interest relevant to this article was reported.
: This study was approved by the Agence Nationale de Se´curite´ du Me´dicament et des Produits de Sante´ (ANSM; IRB number, 2021-A02451-40) and was registered in the ClinicalTrials (identifier number, NCT05215054). This study adhered to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all patients.
